Scientists at the University of California, Berkeley, have created a new COVID-19 therapeutic that could one day make treating SARS-CoV-2 infections as easy as using a nasal spray for allergies.
Aug 9, 2022
0
81
Researchers have taken an important step toward understanding the microscopic battle that plays out between our lung cells and the SARS-CoV-2 virus that causes COVID-19. A UC Berkeley-led study has identified specific proteins ...
Jul 27, 2022
0
91
For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).
Jul 22, 2022
0
112
A team of University of Kentucky researchers led by College of Engineering Professor Dibakar Bhattacharyya, Ph.D., and his Ph.D. student, Rollie Mills, have developed a medical face mask membrane that can capture and deactivate ...
Jul 21, 2022
0
150
A new paper from the laboratory of Lawrence Stern, Ph.D., indicates that some of the antigens on the virus that causes COVID-19 are common across all the human coronaviruses, such as those that cause the common cold, and ...
Jul 21, 2022
0
76
SARS-CoV-2 surrogates can survive on meat products in the refrigerator or the freezer for up to 30 days. Those findings are published in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.
Jul 11, 2022
1
288
Illnesses like the common cold and the flu have become endemic in human populations; everyone gets them every now and then, but for most people, they aren't especially harmful. COVID-19 will eventually transition to endemic ...
Jul 5, 2022
2
151
Last year, pathologist Jeffrey SoRelle, M.D., and colleagues developed CoVarScan, a rapid COVID-19 test that detects the signatures of eight hotspots on the SARS-CoV-2 virus. Now, after testing CoVarScan on more than 4,000 ...
Jul 3, 2022
0
175
More than two years into the COVID-19 pandemic, people are realizing that the "new normal" will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers ...
Jun 29, 2022
0
122
Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including ...
Jun 28, 2022
0
136
